Thus, it is likely that, in the absence of activating FcγR, an FcγRIIB‐mediated efficient removal of IgG IC from the damaged aorta may lower vascular inflammation and oxidative stress, thereby forestalling AAA. The gene discussed is FCGR2B; the disease is triple-A syndrome.